Physician profile
Danielle Harper Key
NPI 1003283441
$1,348.47
in general payments reported to CMS, 2019-2025
15 companies · $287 in 2025
The $287 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $421 · 2023: $191 · 2024: $331 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $809.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.55 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $221.11 | 2022-2025 | |
| Astellas Pharma US INC | $191.25 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $147.85 | 2021-2025 | |
| Exelixis INC. | $112.62 | 2022 | |
| Sumitomo Pharma America, INC. | $91.42 | 2023-2025 | Myfembree |
| Hologic Sales and Service, LLC | $83.48 | 2021-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Organon LLC | $70.20 | 2021-2025 | Nexplanon |
| Therapeuticsmd, INC. | $57.29 | 2021 | |
| Exeltis, USA INC. | $44.21 | 2022-2023 | Slynd |
| Evofem Biosciences, INC. | $30.26 | 2021-2022 | |
| Pfizer INC. | $16.77 | 2022 | |
| Avion Pharmaceuticals | $15.20 | 2022 | |
| Medtronic, INC. | $14.23 | 2022 | |
| Lilly USA, LLC | $14.03 | 2025 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Key listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.